Search results
Jun 8, 2023 · Paxlovid is a combination of two antiviral tablets that’s FDA approved to treat mild to moderate COVID in adults. It’s also authorized for use in certain adolescents ages 12 and older. You may qualify for a Paxlovid prescription directly from your pharmacist without having to see a healthcare provider.
Paxlovid should be administered as early as possible following the appearance of any symptoms and needs to be initiated within 5 days of symptom onset. Who is eligible for Paxlovid? • Paxlovid is for adults and children 12 and older who are at higher risk for developing serious COVID-19 disease that may lead to hospitalization and/or death.
Apr 5, 2024 · Here are a few ways to get Paxlovid if you're eligible: Call your provider . If you test positive for COVID and have a primary care provider who knows your recent medical history, start by asking them if you can get Paxlovid.
Mar 25, 2024 · 1. How does Paxlovid work? Paxlovid is an antiviral therapy that consists of two separate medications packaged together. When you take your three-pill dose, two of those pills will be nirmatrelvir, which inhibits a key enzyme that the COVID virus requires in order to make functional virus particles.
May 11, 2022 · Paxlovid, a five-day course of pills from Pfizer, is at the top of the list of recommended treatments. Studies from the drugmaker showed that – in unvaccinated people at risk of serious COVID...
Aug 22, 2023 · Paxlovid is an oral COVID-19 treatment approved by the Food and Drug Administration (FDA). It can treat mild to moderate COVID in adults at high risk of getting seriously ill.
May 25, 2023 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
